112 related articles for article (PubMed ID: 1920868)
1. [Examination of the inhibitor to factor VIII in non-haemophilic patient].
Suetomo M; Suehisa E; Nishimura K; Toyokawa M; Toku M; Fushimi R; Amino N; Miyai K; Izumi M; Ohtsuka A
Rinsho Byori; 1991 Jul; 39(7):748-52. PubMed ID: 1920868
[TBL] [Abstract][Full Text] [Related]
2. [Remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with infusion of factor VIII and corticosteroid].
Honda J; Egami K; Osabe S; Natori H; Nakamura E; Tanaka K; Naitou K; Kaji M
Rinsho Ketsueki; 1989 Apr; 30(4):520-4. PubMed ID: 2504978
[TBL] [Abstract][Full Text] [Related]
3. [DDAVP administration in a case of congenital combined factor V and factor VIII deficiency].
Takai Y; Hayashi H; Ishimaru F; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1989 Nov; 30(11):2035-40. PubMed ID: 2607619
[TBL] [Abstract][Full Text] [Related]
4. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor to factor VIII in a non-haemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII. A case report.
Chistolini A; Ghirardini A; Tirindelli MC; Moretti T; Mancini F; Di Paolantonio T; Mariani G
Nouv Rev Fr Hematol (1978); 1987; 29(4):221-4. PubMed ID: 3122176
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
7. [Non-hemophilic patient with inhibitor against factor VIII produced after the second delivery].
Akahori M; Yamane T; Hino M; Ohta K; Takubo T; Samori T; Tatsumi N
Rinsho Byori; 1999 Sep; 47(9):891-5. PubMed ID: 10518429
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
Uemura Y; Niiya K; Takeuchi T; Miyoshi I
Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
[TBL] [Abstract][Full Text] [Related]
9. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
Im T; Hintz G
Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor].
Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
C R Seances Acad Sci III; 1981 May; 292(18):1055-7. PubMed ID: 6790137
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
[TBL] [Abstract][Full Text] [Related]
12. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
13. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
14. Screening and diagnosis of coagulation disorders.
Lusher JM
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):778-83. PubMed ID: 8828561
[TBL] [Abstract][Full Text] [Related]
15. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
[TBL] [Abstract][Full Text] [Related]
16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
17. Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
Jackson N; Hashim ZA; Zainal NA; Jamaluddin N
Singapore Med J; 1995 Apr; 36(2):230-1. PubMed ID: 7676276
[TBL] [Abstract][Full Text] [Related]
18. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
20. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
Ishimaru F; Hayashi H; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1990 Sep; 31(9):1493-8. PubMed ID: 2246822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
